FDA NDC Directory · JSON-LD · Markdown

LYNOZYFIC

NDC 61755-056 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION, CONCENTRATE

Generic namelinvoseltamab-gcpt
Labeler / ManufacturerRegeneron Pharmaceuticals, Inc.
Marketing categoryBiologic License Application · App BLA761400
Dosage form / routeINJECTION, SOLUTION, CONCENTRATE · INTRAVENOUS
Active ingredientsLINVOSELTAMAB (200 mg/10mL)
Marketing started20250702
Package count1

External sources

Source: openFDA. Public-domain (CC0).